文献速递儿科与产科急症重症综合管理与镇静镇痛

儿童连续性肾脏替代治疗中的主要不良肾脏事件

Major Adverse Kidney Events in Pediatric Continuous Kidney Replacement Therapy.
PubMed 文献 · JAMA Netw Open · 2024-02-05
一句话结论儿童及青年CKRT患者中65.0%发生MAKE-90,心脏合并症、CKRT启动前ICU停留时间长及未成功脱离CKRT与MAKE-90风险升高相关。

该国际多中心队列研究纳入2015至2021年WE-ROCK注册库中0至25岁因急性肾损伤或液体过负荷接受CKRT的患者969例,排除透析依赖、同期使用ECMO或CKRT用于其他指征者。主要终点MAKE-90(死亡或持续性肾功能障碍,即透析依赖或估算肾小球滤过率较基线下降≥25%)发生率为65.0%。多因素分析显示心脏合并症、CKRT启动前ICU停留时间较长及脱离模式与MAKE-90相关;28天内成功脱离CKRT者MAKE-90风险低于尝试脱离失败者(aOR 0.32)和未尝试脱离者(aOR 0.02)。作者认为需未来前瞻性研究更好地理解脱离模式与实践。

要点

  • 969例接受CKRT的0至25岁患者中,630例(65.0%)在CKRT启动后90天发生MAKE-90。
  • 心脏合并症与MAKE-90风险升高相关(aOR 1.60;95% CI 1.08-2.37)。
  • CKRT启动前ICU停留时间较长与MAKE-90相关(6天 vs 1天的aOR 1.07;95% CI 1.02-1.13)。
  • 28天内成功脱离CKRT者MAKE-90风险低于尝试脱离失败者(aOR 0.32;95% CI 0.22-0.48)和未尝试脱离者(aOR 0.02;95% CI 0.01-0.04)。
  • 作者认为未来需前瞻性研究以更好地理解CKRT脱离模式与实践。

适用人群与场景

  • WE-ROCK注册库中2015至2021年因急性肾损伤或液体过负荷接受CKRT的0至25岁儿童、青少年及青年患者。
  • 排除标准:透析依赖、同期使用体外膜氧合(ECMO)、或因其他指征接受CKRT。

诊断标准与关键阈值

  • 成功脱离CKRT定义为首次尝试脱离后72小时或更长时间未恢复透析,且发生在CKRT启动后28天内。
  • MAKE-90定义为死亡或持续性肾功能障碍(透析依赖或估算肾小球滤过率较基线下降≥25%)。

研究设计与关键结果

  • 研究类型:国际多中心队列研究;样本量969例(男性529例[54.6%];中位[IQR]年龄8.8[1.7-15.0]岁);人群:WE-ROCK注册库中0至25岁因急性肾损伤或液体过负荷接受CKRT的患者。
  • 主要终点:630例(65.0%)发生MAKE-90。
  • 多因素分析:心脏合并症与MAKE-90相关(aOR 1.60;95% CI 1.08-2.37);CKRT启动前ICU停留时间较长与MAKE-90相关(6天 vs 1天的aOR 1.07;95% CI 1.02-1.13);脱离模式与MAKE-90相关。
  • 28天内成功脱离CKRT者MAKE-90风险低于尝试脱离失败者(aOR 0.32;95% CI 0.22-0.48)和未尝试脱离者(aOR 0.02;95% CI 0.01-0.04)。

证据类型、等级与局限

  • 证据类型:国际多中心队列研究(WE-ROCK注册库)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为这些发现强调了该人群不良结局发生率高,并建议未来需前瞻性研究以更好地理解脱离模式与实践。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Continuous kidney replacement therapy (CKRT) is increasingly used in youths with critical illness, but little is known about longer-term outcomes, such as persistent kidney dysfunction, continued need for dialysis, or death.

OBJECTIVE: To characterize the incidence and risk factors, including liberation patterns, associated with major adverse kidney events 90 days after CKRT initiation (MAKE-90) in children, adolescents, and young adults.

DESIGN, SETTING, AND PARTICIPANTS: This international, multicenter cohort study was conducted among patients aged 0 to 25 years from The Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK) registry treated with CKRT for acute kidney injury or fluid overload from 2015 to 2021. Exclusion criteria were dialysis dependence, concurrent extracorporeal membrane oxygenation use, or receipt of CKRT for a different indication. Data were analyzed from May 2 to December 14, 2023.

EXPOSURE: Patient clinical characteristics and CKRT parameters were assessed. CKRT liberation was classified as successful, reinstituted, or not attempted. Successful liberation was defined as the first attempt at CKRT liberation resulting in 72 hours or more without return to dialysis within 28 days of CKRT initiation.

MAIN OUTCOMES AND MEASURES: MAKE-90, including death or persistent kidney dysfunction (dialysis dependence or ≥25% decline in estimated glomerular filtration rate from baseline), were assessed.

RESULTS: Among 969 patients treated with CKRT (529 males [54.6%]; median [IQR] age, 8.8 [1.7-15.0] years), 630 patients (65.0%) developed MAKE-90. On multivariable analysis, cardiac comorbidity (adjusted odds ratio [aOR], 1.60; 95% CI, 1.08-2.37), longer duration of intensive care unit admission before CKRT initiation (aOR for 6 days vs 1 day, 1.07; 95% CI, 1.02-1.13), and liberation pattern were associated with MAKE-90. In this analysis, patients who successfully liberated from CKRT within 28 days had lower odds of MAKE-90 compared with patients in whom liberation was attempted and failed (aOR, 0.32; 95% CI, 0.22-0.48) and patients without a liberation attempt (aOR, 0.02; 95% CI, 0.01-0.04).

CONCLUSIONS AND RELEVANCE: In this study, MAKE-90 occurred in almost two-thirds of the population and patient-level risk factors associated with MAKE-90 included cardiac comorbidity, time to CKRT initiation, and liberation patterns. These findings highlight the high incidence of adverse outcomes in this population and suggest that future prospective studies are needed to better understand liberation patterns and practices.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Fuhrman DY, Stenson EK, Alhamoud I, et al. Major Adverse Kidney Events in Pediatric Continuous Kidney Replacement Therapy. JAMA Netw Open. 2024. PMID: 38393726. doi:10.1001/jamanetworkopen.2024.0243

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。